U.S. flag

An official website of the United States government

Filters

See more specimen types...

Other countries

Results: 1 to 20 of 31

Tests names and labsConditionsGenes, analytes, and microbesMethods

Von Willebrand Disease

GENETIX Centro de Investigación en Genética Humana y Reproductiva
Colombia
71
  • E Sequence analysis of select exons
  • C Sequence analysis of the entire coding region

PlateletGenex Functional Defect Panel (31 genes) (2 Day STAT TAT)

Machaon Diagnostics
United States
2631
  • C Sequence analysis of the entire coding region

VWD-Complete Genetic Panel (2 Day STAT TAT)

Machaon Diagnostics
United States
41
  • C Sequence analysis of the entire coding region

PlateletGenex Thrombocytopenia Panel (26 genes) (2 Day STAT TAT)

Machaon Diagnostics
United States
2226
  • C Sequence analysis of the entire coding region

VWF - NGS including CNV analysis

Centogene AG - the Rare Disease Company
Germany
31
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Hemophilia Complete Genetic Panel (F8, F9 and VWF gene sequencing F8 inversions assays) (2 Day STAT TAT)

Machaon Diagnostics
United States
63
  • E Sequence analysis of select exons
  • C Sequence analysis of the entire coding region

MarrowZoom

Johns Hopkins Genomics DNA Diagnostic Laboratory Johns Hopkins Hospital
United States
250155
  • C Sequence analysis of the entire coding region

von Willebrand disease, type 1, 193400, Autosomal dominant; VWD1 (Von Willebrand disease type 1) (VWF gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

von Willebrand disease, type 1, 193400, Autosomal dominant; VWD1 (Von Willebrand disease type 1) (MLPA)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • D Deletion/duplication analysis

von Willebrand Disease Types 1, 2, and 3 via the VWF Gene

PreventionGenetics, part of Exact Sciences
United States
31
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Von Willebrand Disease (VWF)

Molecular Haemostasis & Thrombosis Viapath - Guy's and St. Thomas' NHS Foundation Trust
United Kingdom
61
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Bleeding Disorders Panel

PreventionGenetics, part of Exact Sciences
United States
7879
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Coagulation Factor Deficiency Panel

PreventionGenetics, part of Exact Sciences
United States
2120
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Clotting factor deficiency panel. 16-gene NGS panel.

Genologica Medica
Spain
2916
  • C Sequence analysis of the entire coding region

Bleeding disorder / coagulopathy panel. NGS panel of 62 genes.

Genologica Medica
Spain
9662
  • C Sequence analysis of the entire coding region

Comprehensive Thrombotic Microangiopathy NGS Panel

Fulgent Genetics
United States
5837
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Thrombosis Disorder NGS Panel

Fulgent Genetics
United States
4618
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Platelet Disorder NGS Panel

Fulgent Genetics
United States
7444
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Von Willebrand Disease (VWF Single Gene Test)

Fulgent Genetics
United States
31
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Comprehensive Thrombosis, Platelet Disorder, and Coagulation Deficiency NGS Panel

Fulgent Genetics
United States
14682
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 31

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.